Table 1 Immunization treatments.

From: Covalent coupling of Spike’s receptor binding domain to a multimeric carrier produces a high immune response against SARS-CoV-2

Groups

RBD (µg/dose)

BLS (µg/dose)

Covalent coupling

RBD: BLS (molar ratio)

Adjuvant (Al(OH)3)

RBD

15

0

–-

–-

No

RBD

15

0

–-

–-

Yes

RBD + BLS

15

17

No

6.6:10

No

RBD-BLS LM

15

70

Yes

1.5:10

No

RBD-BLS HM

15

17

Yes

6.6:10

No

RBD-BLS HM

15

17

Yes

6.6:10

Yes